Liron Pantanowitz, MD, PhD, discusses the key issues pathologists face today, and how technology could help.
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
Free open-source software can be leveraged across diagnostic processes—how can your organization benefit from it?
Prostate Cancer: National Guidelines Have Not Stopped Overuse of Low-Value PSA Screening in Older Males
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.